Horizon Pharma Exec VP Geoffrey Curtis, Responding To Tues. Evening Chatter Co.'s $300M Offering Was Cancelled/Delayed, Confirms To Benzinga Co. Has Not Cancelled Its Ordinary Share Offering Announced Mon. Afternoon